NeuBase Therapeutics
Many diseases remain undruggable with current therapeutic modalities. Nearly all diseases are driven by genetic mutations. NeuBase used precision genetic medicines to “drug the genome” and address disease at its base level, helping millions of patients without therapeutic options.
NeuBase’s website was revamped to showcase its advanced technology for tackling various diseases on the PATrOL platform. Our team designed interactive mechanism of action diagrams for each of the three pipeline elements, providing a clear understanding of how the drug candidates interact with targeted mutations.
In addition, the website featured a patient portal with resources to help individuals navigate their journey with the targeted diseases, along with a publication library with supporting evidence. Unfortunately, the company dissolved in 2024 due to funding issues; however, its technology is being used in other startups.
Additional Website Projects
